Jim Cramer says discipline is what's stopping him from recommending Snap's overvalued stock. » Read More
By: Elizabeth Gurdus
Jim Cramer zeroes in on why the market didn't crash after the Obamacare replacement failed. » Read More
"I still think that Trump with Gary Cohn and a different team working to try to get this through we'll have some luck," Cramer says. » Read More
By: Lauren Thomas
Chicago Fed. President Evans said Monday that inflation looks "well on its way" to reaching economic objectives. » Read More
Intuit shares slipped more than 3 percent Wednesday after the company said it expects a weak first-quarter.
Wednesday is the anniversary of the Aug. 24 'flash crash,' in which the Dow fell 1,000 points in early trading. It's not the first time the markets have crashed.
Best Buy continues its post-earnings surge, and one trader believes the stock could keep rallying.
For the entire month of August, the 10-year bond yield has pretty much been stuck between 1.50 and 1.59 percent.
Dunkin' Brands CEO Nigel Travis tells CNBC he's using new products and technology to get more young people in the door.
Bank of America Merrill Lynch reaffirmed its buy rating on Lowe's and added the retailer to its US1 top ideas list.
Shares of Express sink after the company reported weaker-than-expected quarterly sales and earnings.
After Pfizer's $14 billion proposed acquisition of Medivation, these biotech stocks could emerge as winners, if history is any guide.
Some of the names on the move ahead of the open.
Priscilla Hancock of JPMorgan Asset Management explains when she believes the Federal Reserve will hike interest rates.
The Japanese yen has been a star performer in 2016, and everyone is wondering where this currency goes next.
The "Fast Money" traders share their first moves for the market open.
Jim Cramer is seeing signs that companies are buying back stocks as a message that they are undervalued.
Jim Cramer goes off the charts to find two stocks that could explode higher in the return of retail.
The furniture maker said it saw its quarterly same-store sales decline by 1.9 percent.
UBS analysts upgraded their rating of CF Industries and increased a 12-month price target, sending the company's shares higher.
Clovis Oncology shares shot up more than 26 percent Tuesday after the FDA accepted the company's new drug application.
Both Tesla Motors and SolarCity shares gave up their gains after Tesla announced new versions of its Model S and Model X.
Toll Brothers reported a rise in revenue for the fourth straight quarter, beating analysts' estimates.
As major averages continue to scale new highs, one Wall Street firm believes the stock market rally is getting overdone.
Get the best of CNBC in your inbox